SOX2 and endometrial cancer: We next compared SOX2 expression in the nuclei of normal FTE of patients with benign conditions and patients with endometrial cancer (age-matched cases) and the normal FTE and corresponding ovarian tumors from patients diagnosed with HGSOC (Table 2, Supplementary Table 7).